A large number of clinical studies have shown that EGFR-TKI can significantly prolong the disease-free survival of patients compared with chemotherapy.9,10 At present, the treatment of cancer patients tends to be multidisciplinary, but there are still many controversies about the best treatment for NSCLC with brain metastasis. Here, EGFR is linked to non-small cell lung carcinoma.